Mass spectrometry for studying the interaction between small molecules and proteins

Current Proteomics

Volumn 5, Issue 1, 2008, Pages 20-34

  Calvo, Enrique ^a   Camafeita, Emilio ^a   Díaz, J Fernando ^b   López, Juan Antonio ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Affinity based probes; Affinity based protein profiling; Chemical proteomics; Drug discovery; ESI; Ligand; MALDI; MS

Indexed keywords

EID: 43049117162     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016408783955128     Document Type: Review

References (115)

1. Adam, G.C., Sorensen, E.J. and Cravatt, B.F. (2002). Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat. Biotechnol. 20: 805-9.
2. Al-Mawsawi, L.Q., Fikkert, V., Dayam, R., Witvrouw, M., Burke, T.R., Borchers, C.H. and Neamati, N. (2006). Discovery of a small-molecule HIV-1 integrase inhibitor-binding site. Proc. Natl. Acad. Sci. USA 103: 10080-5.
3. Bach, S., Knockaert, M., Reinhardt, J., Lozach, O., Schmitt, S., Baratte, B., Koken, M., Coburn, S.P., et al. (2005). Roscovitine targets, protein kinases and pyridoxal kinase. J. Biol. Chem. 280: 31208-19.
4. Back, J.W., de Jong, L., Muijsers, A.O. and de Koster, C.G. (2003). Chemical cross-linking and mass spectrometry for protein structural modeling. J. Mol. Biol. 331: 303-13.
5. Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., et al. (2007). Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 25: 1035-44.
6. Barglow, K.T. and Cravatt, B.F. (2004). Discovering disease-associated enzymes by proteome reactivity profiling. Chem. Biol. 11: 1523-31.
7. Barglow, K.T. and Cravatt, B.F. (2007). Activity-based protein profiling for the functional annotation of enzymes Nat. Methods 4: 822-7.
8. Berger, A.B., Witte, M.D., Denault, J.B., Sadaghiani, A.M., Sexton, K.M., Salvesen, G.S. and Bogyo, M. (2006). Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol. Cell 23: 509-21.
9. Biswall, B.K., Wang, M., Cherney, M.M., Chan, L., Yannopoulos, C.G., Bilimoria, C., Bedard, J. and James, M.N.G. (2006). Non-nucleoside inhibitors binding to Hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition. J. Mol. Biol. 361: 33-45.
10. Buey, R.M., Díaz, J.F., Andreu, J.M., O'Brate, A., Giannakakou, P., Nicolaou, K.C., Sasmal, P.K., Ritzen, A., et al. (2004). Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity. Chem. Biol. 11: 225-36.
11. Buey, R.M., Calvo, E., Barasoain, I., Pineda, O., Edler, M.C., Matesanz, R., Cerezo, G., Vanderwal, C.D., et al. (2007). Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites. Nat. Chem. Biol. 3: 117-25.
12. Buijs, J. and Franklin, G.C. (2005). SPR-MS in functional proteomics. Brief. Funct. Genomic Proteomic. 4: 39-47.
13. Burbaum, J. and Tobal, G.M. (2002). Proteomics in drug discovery. Curr. Op. Chem. Biol. 6: 427-33.
14. Busenlehner, L.S. and Armstrong, R.N. (2005). Insights into enzyme structure and dynamics elucidated by amide H/D exchange mass spectrometry. Arch. Biochem. Biophys. 433: 34-46.
15. Caprioli, R.M., Farmer, T.B. and Gile, J. (1997). Molecular imaging of biological samples: Localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 69: 4751-60.
16. Chan, B.S, Satriano, J.A. and Schuster, V.L. (1999). Mapping the substrate binding site of the prostaglandin transporter PGT by cysteine scanning mutagenesis. J. Biol. Chem. 274: 25564-70.
17. Chan, E.W., Chattopadhaya, S., Panicker, R.C., Huang, X. and Yao, S.Q. (2004). Developing photoactive affinity probes for proteomic profiling: hydroxamate-based probes for metalloproteases. J. Am. Chem. Soc. 126: 14435-46.
18. Chiang, K.P., Niessen, S., Saghatelian, A. and Cravatt, B.F. (2006). An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem. Biol. 13: 1041-50.
19. Chitta, R.K., Rempel, D.L., Grayson, M.A., Remsen, E.E. and Gross, M.L. (2006). Application of SIMSTEX to oligomerization of insulin analogs and mutants. J. Am. Soc. Mass Spectrom. 17: 1526-34.
20. De Souza, N. (2007). From structure to function. Nat. Methods 4: 771.
21. Dragic, T., Trkola, A., Thompson, D.A.D., Cormier, E.G., Kajumo, F.A., Maxwell, E., Lin, S.W., Ying, W., et al. (2000). A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. USA 97: 5639-44.
22. Ellis, J. and Seidenberg, M. (2000). Site-directed mutagenesis implicates a threonine residue in TM6 in the subtype selectivities of UH-AH 37 and pirenzepine at muscarinic receptors. Pharmacology 61: 62-9.
23. Engen, J.R. and Smith, D.L. (2001). Investigating protein structure and dynamics by hydrogen exchange MS. Anal. Chem. 73: 256A-65A.
24. Englander, S.W. (2006). Hydrogen exchange and mass spectrometry: A historical perspective. J. Am. Soc. Mass Spectrom. 17: 1481-9.
25. English, A.C., Done, S.H., Caves, L.S., Groom, C.R. and Hubbard, R.E. (1999). Locating interaction sites on proteins: the crystal structure of thermolysin soaked in 2% to 100% isopropanol. Proteins 37: 628-40.
26. English, A.C., Groom, C.R. and Hubbard, R.E. (2001). Experimental and computational mapping of the binding surface of a crystalline protein. Protein Eng. 14: 47-59.
27. Evans, M.J. and Cravatt, B.F. (2006). Mechanism-based profiling of enzyme families. Chem. Rev. 106: 3279-301.
28. Fenn, J.B., Mann, M., Meng, C.K., Wong, S.F. and Whitehouse, C.M. (1989). Electrospray Ionisation for Mass Spectrometry of Large Biomolecules. Science 246: 64-71.
29. Fonovic, M., Verhelst, S.H., Sorum, M.T. and Bogyo, M. (2007). Proteomic evaluation of chemically cleavable activity based probes. Mol. Cell. Proteomics 6: 1761-70.
30. Gad, S. (Editor). (2005). Drug discovery handbook. John Wiley & Sons, Inc., Hoboken, New Jersey.
31. Gartner, C.A., Elias, J.E., Bakalarski, C.E. and Gygi, S.P. (2007). Catchand-release reagents for broadscale quantitative proteomics analyses. J. Proteome Res. 6: 1482-91.
32. Gharbi, S., Garzon, B., Gayarre, J., Timms, J. and Perez-Sala, D. (2007). Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin. J. Mass Spectrom. 42: 1474-84.
33. Godl, K., Wissing, J., Kurtenbach, A., Habenberger, P., Blencke, S., Gutbrod, H., Salassidis, K., Stein-Gerlach, M., et al. (2003). An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc. Natl. Acad. Sci. USA 100: 15434-39.
34. Graves, P.R., Kwiek, J.J., Fadden, P., Ray, R., Hardeman, K., Coley, A.M., Foley, M. and Haystead, T.A. (2002). Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol. Pharmacol. 62: 1364-72.
35. Greenbaum, D., Medzihradszky, K.F., Burlingame, A. and Bogyo, M. (2000). Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 7: 569-81.
36. Greenbaum, D.C., Arnold, W.D., Lu, F., Hayrapetian, L., Baruch, A., Krumrine, J., Toba, S., Chehade, K., et al. (2002a). Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem. Biol. 9: 1085-94.
37. Greenbaum, D.C., Baruch, A., Grainger, M., Bozdech, Z., Medzihradszky, K.F., Engel, J., DeRisi, J., Holder, A.A., et al. (2002b). A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298: 2002-6.
38. Guiffant, D., Tribouillard, D., Gug, F., Galons, H., Meijer, L., Blondel, M. and Bach, S. (2007). Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography. Biotechnol. J. 2: 68-75.
39. Hajduk, P.J., Huth, J.R. and Fesik, S.W. (2005). Druggability indices for protein targets derived from NMR-based screening data. J. Med. Chem. 48: 2518-25.
40. Halperin, I., Ma, B., Wolfson, H. and Nussinov, R. (2002). Principles of docking: an overview of search algorithms and a guide to scoring functions. Proteins 47: 409-43.
41. Heftmann, E. (Guest Ed). (2001). Affinity chromatography. J. Biochem. Biophys. Methods Special Issue 49: 1-743.
42. Hekmat, O., Kim, Y.W., Williams, S.J., He, S. and Withers, S.G. (2005). Active-site peptide "fingerprinting" of glycosidases in complex mixtures by mass spectrometry. Discovery of a novel retaining beta-1,4-glycanase in Cellulomonas fimi. J. Biol. Chem. 280: 35126-35.
43. Hermann, J.C., Marti-Arbona, R., Fedorov, A.A., Fedorov, E., Almo, S.C., Shoichet, B.K. and Raushel, F.M. (2007). Structure-based activity prediction for an enzyme of unknown function. Nature 16: 775-9.
44. Hoofnagle, A.N., Resing, K.A. and Ahn, N.G. (2003). Protein analysis by hydrogen exchange mass spectrometry. Annu. Rev. Biophys. Biomol. Struct. 32: 1-25.
45. Hopfgartner, G., Varesio, E., Tschäppät, V., Grivet, C., Bourgogne, E. and Leuthold, L.A. (2004). Triple quadrupole linear ion trap mass spectrometer for the analysis of small molecules and macromolecules. J. Mass Spectrom. 39: 845-55.
46. Hsieh, Y., Casale, R., Fukuda, E., Chen, J., Knemeyer, I., Wingate, J., Morrison, R. and Korfmacher, W. (2006). Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct measurement of clozapine in rat brain tissue. Rapid Commun. Mass Spectrom. 20: 965-72.
47. Huang, N., Kalyanaraman, C., Bernacki, K. and Jacobson, M.P. (2006). Molecular mechanics methods for predicting protein-ligand binding. Phys. Chem. Chem. Phys. 8: 5166-77.
48. Jeffery, D.A. and Bogyo, M. (2003). Chemical proteomics and its application to drug discovery. Curr. Opin. Biotechnol. 14: 87-95.
49. Jessani, N., Liu, Y., Humphrey, M. and Cravatt, B.F. (2002). Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc. Natl. Acad. Sci. USA 99: 10335-40.
50. Jessani, N., Niessen, S., Wei, B.Q., Nicolau, M., Humphrey, M., Ji, Y., Han, W., Noh, D.Y., et al. (2005). A streamlined platform for high-content functional proteomics of primary human specimens. Nat. Methods 2: 691-7.
51. Jiménez-Barbero, J., Canales, A., Northcote, P.T., Buey, R.M., Andreu, J.M. and Díaz, J.F. (2006). NMR determination of the bioactive conformation of peloruside A bound to microtubules. J. Am. Chem. Soc. 128: 8757-65.
52. John, H. (2005). Liquid chromatography-mass spectrometry in peptide drug discovery and development. Anal. Bioanal. Chem. 381: 51-3.
53. Karas, M. and Hillenkamp, F. (1988). Laser desorption ionization of proteins with molecular mass exceeding 10,000 Daltons. Anal. Chem. 60: 2299-301.
54. Kato, D., Boatright, K.M., Berger, A.B., Nazif, T., Blum, G., Ryan, C., Chehade, K.A., Salvesen, G.S., et al. (2005). Activity-based probes that target diverse cysteine protease families. Nat. Chem. Biol. 1: 33-8.
55. Khatib-Shahidi, S., Andersson, M., Herman, J.L., Gillespie, T.A. and Caprioli, R.M. (2006). Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal. Chem. 78: 6448-56.
56. Kidd, D., Liu, Y. and Cravatt, B.F. (2001). Profiling serine hydrolase activities in complex proteomes. Biochemistry 40: 4005-15.
57. Koh, J.T. (2003). Making virtual screening a reality. Proc. Natl. Acad. Sci. USA 100: 6902-3.
58. Komives, E.A. (2005). Protein-protein interaction dynamics by amide H/2H exchange mass spectrometry. Int. J. Mass Spectrom. 240: 285-90.
59. Korfmacher, W.A. (2005). Principles and applications of LC-MS in new drug discovery. Drug Discov. Today 10: 1357-67.
60. Köster, H., Little, D.P., Luan, P., Muller, R., Siddiqi, S.M., Marappan, S. and Yip, P. (2007). Capture compound mass spectrometry: A technology for the investigation of small molecule protein interactions. Assay Drug Develop. Technol. 5: 381-90.
61. Kumar, S., Zhou, B., Liang, F., Wang, W-Q., Huang, Z. and Zhang, Z-Y. (2004). Activity-based probes for protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 101: 7943-8.
62. Lamos, S.M., Krusemark, C.J., McGee, C.J., Scalf, M., Smith, L.M. and Belshaw, P.J. (2006). Mixed isotope photoaffinity reagents for identification of small-molecule targets by mass spectrometry. Angew. Chem. Int. Ed. Engl. 45: 4329-33.
63. Lanman, J. and Prevelige, P.E. Jr. (2004). High-sensitivity mass spectrometry for imaging subunit interactions: Hydrogen/deuterium exchange. Curr. Opin. Struct. Biol. 14: 181-8.
64. Li, W., Blankman, J.L. and Cravatt, B.F. (2007). A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. J. Am. Chem. Soc. 129: 9594-5.
65. Li, Y.M., Xu, M., Lai, M.T., Huang, Q., Castro, J.L., DiMuzio-Mower, J., Harrison, T., Lellis, C., et al. (2000). Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405: 689-94.
66. Liu, Y., Patricelli, M.P. and Cravatt, B.F. (1999). Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA 96: 14694-9.
67. Mattos, C. and Ringe, D. (1996). Locating and characterizing binding sites on proteins. Nat. Biotechnol. 14: 595-9.
68. Mattos, C., Bellamacina, C.R., Peisach, E., Pereira, A., Vitkup, D., Petsko, G.A. and Ringe, D. (2006). Multiple solvent crystal structures: probing binding sites, plasticity and hydration. J. Mol. Biol. 357: 1471-82.
69. McDonald, C. and Li, L. (2005). Limited proteolysis combined with isotope labeling and quantitative LC-MALDI MS for monitoring protein conformational changes: a study on calcium-binding sites of cardiac Troponin C. Anal. Chim. Acta 534: 3-10.
70. Mynarcik, D.C., Williams, P.F., Schaffer, L., Yu, G.Q. and Whittaker, J. (1997). Identification of common ligand binding determinants of the insulin and insulin-like Growth Factor 1 receptors. J. Biol. Chem. 272: 18650-5.
71. Nazif, T. and Bogyo, M. (2001). Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors. Proc. Natl. Acad. Sci. USA 98: 2967-72.
72. Okerberg, E.S., Wu, J., Zhang, B., Samii, B., Blackford, K., Winn, D.T., Shreder, K.R, Burbaum, J.J., et al. (2005). High-resolution functional proteomics by active-site peptide profiling. Proc. Natl. Acad. Sci. USA 102: 4996-5001.
73. Otting, G. and Wüthrich, K. (1990). Heteronuclear filters in two-dimensional [1H,1H]-NMR spectroscopy: combined use with isotope labeling for studies of macromolecular conformation and intermolecular interactions. Quart. Rev. Biophys. 23: 39-96.
74. Patricelli, M.P., Giang, D.K., Stamp, L.M. and Burbaum, J.J. (2001). Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes. Proteomics 1: 1067-71.
75. Patricelli, M.P., Szardenings, A.K., Liyanage, M., Nomanbhoy, T.K., Wu, M., Weissig, H., Aban, A., Chun, D., et al. (2007). Functional interrogation of the kinome using nucleotide acyl phosphates. Biochemistry 46: 350-8.
76. Powell, K.D., Ghaemmaghami, S., Wang, M.Z., Ma, L., Oas, T.G. and Fitzgerald, M.C. (2002). A general mass spectrometry-based assay for the quantitation of protein-ligand binding interactions in solution. J. Am. Chem. Soc. 124: 10256-7.
77. Prakash, C., Shaffer C.L. and Nederman, A. (2007). Analytical strategies for identifying drug metabolites. Mass Spectrom. Rev. 26: 340-69.
78. Reyzer, M.L., Caldwell, R.L., Dugger, T.C., Forbes, J.T., Ritter, C.A., Guix, M., Arteaga, C.L. and Caprioli, R.M. (2004). Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res. 64: 9093-100.
79. Ross, P.L., Huang, Y.N., Marchese, J.N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., et al. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using aminereactive isobaric tagging reagents. Mol. Cell. Proteomics 3: 1154-69.
80. Sadaghiani, A.M., Verhelst, S.H. and Bogyo, M. (2007). Tagging and detection strategies for activity-based proteomics. Curr. Opin. Chem. Biol. 11: 20-8.
81. Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M. and Cravatt, B.F. (2004a). Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl. Acad. Sci. USA 101: 10000-5.
82. Saghatelian, A., Trauger, S.A., Want, E.J., Hawkins, E.G., Siuzdak, G. and Cravatt, B.F. (2004b). Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43: 14332-9.
83. Salisbury, C.M. and Cravatt, B.F. (2007). Activity-based probes for proteomic profiling of histone deacetylase complexes. Proc. Natl. Acad. Sci. USA 104: 1171-6.
84. Sato, S., Kwon, Y., Kamisuki, S., Srivastava, N., Mao, Q., Kawazoe, Y. and Uesugi, M. (2007). Polyproline-rod approach to isolating protein targets of bioactive small molecules: isolation of a new target of indomethacin. J. Am. Chem. Soc. 129: 873-80.
85. Schuchardt, S. and Sickmann, A. (2007). Protein identification using mass spectrometry: a method overview. EXS 97: 141-70.
86. Shields, S.J., Oyeyemi, O., Lightstone, F.C. and Balhorn, R. (2003). Mass spectrometry and non-covalent protein-ligand complexes: Confirmation of binding sites and changes in tertiary structure. J. Am. Soc. Mass Spectrom. 14: 460-70.
87. Shiyama, T., Furuya, M., Yamazaki, A., Terada, T. and Tanaka, A. (2004). Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins. Bioorg. Med. Chem. 12: 2831-41.
88. Shuker, S.B., Hajduk, P.J., Meadows, R.P. and Fesik, S.W. (1996). Discovering high-affinity ligands for proteins: SAR by NMR. Science 274: 1531-4.
89. Sieber, S.A., Niessen, S., Hoover, H.S. and Cravatt, B.F. (2006). Proteomic profiling of metalloprotease activities with cocktails of active-site probes. Nat. Chem. Biol. 2: 274-81.
90. Sijwali, P.S., Kato, K., Seydel, K.B., Gut, J., Lehman, J., Klemba, M., Goldberg, D.E., Miller, L.H., et al. (2004). Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites. Proc. Natl. Acad. Sci. USA 101: 8721-6.
91. Sijwali, P. S., Koo, J., Singh, N. and Rosenthal, P. J. (2006). Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. Molec. Biochem. Parasitol. 150: 96-106.
92. Sinz, A. (2003). Chemical cross-linking and mass spectrometry for mapping three-dimensional structures of proteins and protein complexes. J. Mass Spectrom. 38: 1225-37.
93. Sinz, A. (2007). Isotope-labeled photoaffinity reagents and mass spectrometry to identify protein-ligand interactions. Angew. Chem. Int. Ed. 46: 660-2.
94. Smith, D.L., Deng, Y. and Zhang, Z. (1997). Probing the non-covalent structure of proteins by amide hydrogen exchange and mass spectrometry. J. Mass Spectrom. 32: 135-46.
95. Snyder, J.R., Hall, A., Ni-Komatsu, L., Khersonsky, S.M., Chang, Y.T. and Orlow, S.J. (2005). Dissection of melanogenesis with small molecules identifies prohibitin as a regulator. Chem. Biol. 12: 477-84.
96. Song, L., Kalyanaraman, C., Fedorov, A.A., Fedorov, E.V., Glasner, M.E., Brown, S., Imker, H.J., Babbitt, P.C., et al. (2007). Prediction and assignment of function for a divergent N-succinyl amino acid racemase. Nat. Chem. Biol. 3: 486-91.
97. Speers, A.E. and Cravatt, B.F. (2004). Profiling enzyme activities in vivo using click chemistry methods. Chem. Biol. 11: 535-46.
98. Strupat, K., Sagi, D., Bönisch, H., Schäfer, G. and Peter-Katalinic, J. (2000). Oligomerization and substrate binding studies of the adenylate kinase from Sulfolobus acidocaldarius by matrix-assisted laser desorption/ionization mass spectrometry. Analyst 125: 563-67.
99. Taunton, J., Hassig, C.A. and Schreiber, S.L. (1996). A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272: 408-11.
100. Terstappen, G.C., Schlüpen, C., Raggiaschi, R. and Gaviraghi, G. (2007). Target deconvolution strategies in drug discovery. Nature Rev. Drug Discov. 6: 891-903.
101. Triolo, A., Altamura, M., Dimoulas, T., Guidi, A., Lecci, A. and Tramontana, M. (2005). In vivo metabolite detection and identification in drug discovery via LC-MS/MS with data-dependent scanning and postacquisition data mining. J. Mass Spectrom. 40: 1572-82.
102. Trynda-Lemiesz, L. (2004). Paclitaxel-HSA interaction. Binding sites on HSA molecule. Bioorg. Med. Chem. 12: 3269-75.
103. Usui, T., Watanabe, H., Nakayama, H., Tada, Y., Kanoh, N., Kondoh, M., Asao, T., Takio, K., et al. (2004). The anticancer natural product pironetin selectively targets Lys352 of -Tubulin. Chem. Biol. 11: 799-806.
104. Veenstra, T.D. (2006). Proteomic approaches in drug discovery. Drug Discov. Today Technol. 3: 433-40.
105. Visser, N.F., Scholten, A., van den Heuvel, R.H. and Heck, A.J. (2007). Surface-plasmon-resonance-based chemical proteomics: efficient specific extraction and semiquantitative identification of cyclic nucleotide-binding proteins from cellular lysates by using a combination of surface plasmon resonance, sequential elution and liquid chromatography-tandem mass spectrometry. ChemBiochem. 8: 298-305.
106. Vocadlo, D.J., Hang, H.C., Kim, E.J., Hanover, J.A. and Bertozzi, C.R. (2003). A chemical approach for identifying O-GlcNAc-modified proteins in cells. Proc. Natl. Acad. Sci. USA 100: 9116-21.
107. Vogel, M. (2002). LC/MS applications in drug development. Drug Discov. Today 7: 950.
108. Waitt, G.M., Xu, R., Wisely, G.B. and Williams, J.D. (2007). Automated inline gel filtration for native state mass spectrometry. J. Am. Soc. Mass Spectrom. Epub ahead of print, 2007 May 23. doi:10.1016/j.jasms.2007.05.008.
109. Wang, G., Shang, L., Burgett, A.W., Harran, P.G. and Wang, X. (2007). Diazonamide toxins reveal an unexpected function for ornithine δ-amino transferase in mitotic cell division. Proc. Natl. Acad. Sci. USA 104: 2068-73.
110. Wissing, J., Jansch, L., Nimtz, M., Dieterich, G., Hornberger, R., Keri, G., Wehland, J. and Daub, H. (2007). Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. Mol. Cell. Proteomics 6: 537-47.
111. Wright, A.T. and Cravatt, B.F. (2007). Chemical proteomic probes for profiling cytochrome P450 activities and drug interactions in vivo. Chem. Biol. 14: 1043-51.
112. Xu, R.N., Fan, L., Rieser, M.J. and El-Shourbagy, T.A. (2007). Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. J. Pharm. Biomed. Anal. 44: 342-55.
113. Yanes, O., Villanueva, J., Querol, E. and Aviles, F.X. (2007). Detection of non-covalent protein interactions by 'intensity fading' MALDI-TOF mass spectrometry: applications to proteases and protease inhibitors. Nat. Protoc. 2: 119-30.
114. Yu, Y., Sweeney, M.D., Saad, O.M. and Leary, J.A. (2006). Potential Inhibitors of Chemokine Function: Analysis of Noncovalent Complexes of CC Chemokine and Small Polyanionic Molecules by ESI FT-ICR Mass Spectrometry. J. Am. Soc. Mass Spectrom. 17: 524-35.
115. Zhu, M.M., Rempel, D.L., Du, Z. and Gross, M.L. (2003). Quantification of protein-ligand interactions by mass spectrometry, titration, and H/D exchange: PLIMSTEX. J. Am. Chem. Soc. 125: 5252-3.